glp-1 receptor agonists in pediatric and adolescent obesity Weighing up the options: childhood intervention to tackle Neurobiological Mechanisms and Therapeutic Potential

Your muscles become better at taking in and using glucose for energy

L.et al (2021)

Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis

Finally, exendin4 significantly inhibited NF B (p65) translocation into the nucleus in MCF7 cells, a mechanism that was eliminated by the GLP1R antagonist exendin, proving again that this interaction occurs via GLP1R activation

Clinical eligibility for GLP-1 drugs was determined using BMI and the following comorbidities as specified in NHIS: coronary heart disease, prior stroke, prior heart attack, angina, high blood pressure, and high cholesterol

Since elevated liver enzymes can be a concerning side effect for individuals taking GLP-1 receptor agonists, liver function should be monitored regularly